MICA and melanoma: On the other hand, no differences were found in the genotype distribution of affinity variants between melanoma patients and controls, unlike what was observed in other pathologic settings [25, 29, 37, 39], where MICA-129 genotype could be considered as a biomarker of disease susceptibility and/or protection.